Clinical Trials in Ohio

Showing 5081-5100 of 15,929 trials

Aquatic Therapy for ASD

NCT05092321

This is an aquatic occupational therapy group for children between the ages of 3-12 that have an autism diagnosis. Intervention will focus on increasing the child's safety swim skills.

Autism Spectrum Disorder

Ohio State University60 participantsStarted Sep 2021

Columbus, Ohio, United States

COMPLETED32 miles

Young Adult EC Use and Respiratory Outcomes

NCT04395274

E-cigarette (EC) use continues to increase among youth, and EC may be detrimental to youth respiratory health. Public health officials and the Food and Drug Administration (FDA) can now regulate ECs. The proposed study uses naturalistic assessments called ecological momentary assessment (EMA) to understand how ECs use may impact the respiratory health of youth and young adult users compared to never-using peers.

E Cig Use

Ohio State University Comprehensive Cancer Center115 participantsStarted Dec 2021

Columbus, Ohio, United States

TERMINATEDPhase 232 miles

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

NCT03640481

This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025 in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of systemic therapy

Chronic Graft-versus-host-disease

Kadmon, a Sanofi Company159 participantsStarted Oct 2018

Phoenix, Arizona, United States • Tucson, Arizona, United States • Duarte, California, United States +32 more locations

Aquatic Therapy for ASD

Young Adult EC Use and Respiratory Outcomes

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Find Trials by Condition in Ohio

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Osia 2 Pediatric Expansion Study

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

A Drug-drug Interaction Study of Avapritinib and Midazolam

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Study of ATH434 in Participants with Multiple System Atrophy

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

AAV Gene Therapy Study for Subjects with PKU